Tip Sheet: Looking ahead to 2021, COVID-19 vaccines, improving health outcomes — and more

Summaries of recent Fred Hutch research findings and other news

SEATTLE —Jan. 6, 2020 —Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.

Looking ahead to 2021

Scientists predict progress against COVID-19, cancer in 2021
Just as the COVID-19 pandemic dominated our lives in 2020, it was a huge focus for many researchers at Fred Hutch. That focus is likely to continue in 2021. We talked to researchers across Fred Hutch about what they are expecting in 2021 — not only in COVID-19, but also in the diseases that we’ve been facing  year after year.
Media contact: Claire Hudson, crhudson@fredhutch.org

COVID-19 vaccines

Vaccines stop COVID-19 symptoms, but do they stop transmission?
As Americans celebrate the rollout of the first COVID-19 vaccines, scientists are racing to find out whether these new shots not only protect individuals from disease, but also prevent them from transmitting the coronavirus to others. A series of vaccine selfies were highlighted on Fred Hutch’s Twitter.
Media contact: media@fredhutch.org

Improving health outcomes

Democratizing DNA-based health risk scores
Scientists with the PAGE consortium (Population Architecture using Genomics and Epidemiology) received a $9.8M grant to improve genetic risk prediction for cardiovascular disease in racially and ethnically diverse populations.
Media contact: media@fredhutch.org

Breast cancer research

What’s new in breast cancer research? SABCS20 goes virtual
The San Antonio Breast Cancer Symposium was a virtual event this pandemic year, allowing thousands of breast cancer researchers, oncologists and patient advocates from around the world to log in for four full days of science and resilience writ large. Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more.
Media contact:
Molly McElroy, mwmcelro@fredhutch.org

Cell biology

Repair of key immune organ triggered by change in how immune cells die
Scientists learn how dying T cells promote regrowth of thymus. These findings could help researchers develop therapies to enhance repair of the thymus after damage from cancer treatment, infection or aging. By boosting immune function, such therapies may also someday improve the effectiveness of vaccines or certain cancer immunotherapies.
Media contact: Molly McElroy, mwmcelro@fredhutch.org

Other notable news

Essential workers illustrate the Heart of the Hutch

Working from home and showing the Heart of the Hutch

# # #

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.